Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005)
Clinical trial NCT03635086 · COMPLETED
Trial details
- NCT number
- NCT03635086
- Sponsor
- Themis Bioscience GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-22
- Primary completion
- 2019-01-25
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.